Pfizer Bid For Wyeth Could Top $65 Billion: Wsj

Pfizer bid for Wyeth could top $65 billion: WSJ

Pfizer Inc. reportedly is close to an agreement to acquire rival drug maker Wyeth for between $65 billion and $70 billion in a cash-and-stock deal that could be announced as early as next week,

Sections:  news   business   
Topics:  drugs   drugs industry   pfizer   wyeth   
RELATED ARTICLES
BING NEWS:
  • An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock
    But that belies the reality of the situation; after bringing in a record haul of more than $100.3 billion in revenue in ... issues that are blocking the top line from trickling down into ...
    10/10/2024 - 9:45 pm | View Link
  • Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
    Apple sales 4:36 PM UTC · Updated ago Climate & Energycategory Exxon's $8.6 billion profit beats as record output offsets weak fuel prices 4:36 PM UTC · Updated ago Climate & Energycategory ...
    10/8/2024 - 3:52 am | View Link
  • Pfizer swallows Wyeth, validates niche buster
    It is also undergoing a phase 2b study in Peyronie's disease, with top-line data expected ... already scuppered one deal: Wyeth's reported $1.35 billion bid for the vaccine maker Crucell, of ...
    04/27/2019 - 6:08 pm | View Link
  • More

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News